Kindred Biosciences, Inc.
KINDelisted Aug 27, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001561743
Kindred Biosciences, Inc. was delisted on Aug 27, 2021; its insiders filed their last Form 4 on Sep 13, 2021; 87 institutions reported holding it in 13F filings for Q2 2021, worth $311.0M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Kindred Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 87 | 2 | 1 | −84 |
| Shares | 33.9M | 76.9K | 2.50K | −33.8M (−100.0%) |
| Value | $311.0M | $705.0K | $11.0K | −$310.3M (−100.0%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Kindred Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVA Family Office, LLC | 2,500 | $11.0K | 0.01% |
Sold out (85)
Institutions that held Kindred Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (2)
Institutions that held Kindred Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 76,200 | $699.0K |
| CWM, LLC | 676 | $6.00K |